Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TDOC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTeladoc expands board to 10 directors, appoints former Verisk Analytics COO Mark Anquillare
Filed August 3, 2026 · Period ending August 3, 2026 · ~1 min read
Key Changes
-
medium
Board expanded from 9 to 10 directors and appointed Mark V. Anquillare, former president and COO of Verisk Analytics, effective August 3, 2026.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
medium
Anquillare designated as independent director and audit committee financial expert under SEC and NYSE rules; assigned to both audit and compensation committees.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR → -
low
Anquillare brings 30+ years of financial and executive leadership experience, including serving as Verisk's CFO from 2007 and leading the company through its 2009 IPO.
Exhibit 99.1 view on EDGAR →
Summary
Teladoc Health expanded its board from nine to ten directors and appointed Mark V. Anquillare to the new seat, effective August 3, 2026. Anquillare previously served as president and chief operating officer of Verisk Analytics, a data analytics and technology company serving the insurance industry, and led Verisk through its 2009 IPO as CFO.
The board designated him as an independent director and an audit committee financial expert under SEC and NYSE rules, and immediately assigned him to both the audit and compensation committees. The appointment adds financial and operational expertise to Teladoc's board at a time when the company continues to navigate its virtual care business.
Anquillare's background in leading a data analytics company through public-market milestones and his current board service at Guidewire Software (where he chairs the audit committee) suggest the board values his financial oversight and governance experience. The expansion to ten directors and the immediate committee assignments indicate the board sought to strengthen its audit and compensation oversight capabilities.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Effective August 3, 2026, the Board of Directors (the “Board”) of Teladoc Health, Inc. (the “Company”) increased the number of directors on the Board to ten and appointed Mark V. Anquillare as a director of the Company. Mr. Anquillare was additionally appointed to each of the audit committee and the compensation committee of the Board.
The Board expanded from nine to ten directors and appointed Mark V. Anquillare to fill the new seat. He was immediately assigned to both the audit committee and compensation committee, indicating the Board values his financial and compensation expertise for these oversight roles.
Added in current filing · verify on EDGAR →
The Board has determined that Mr. Anquillare is an independent director within the meaning of the New York Stock Exchange listing standards and is an “audit committee financial expert” under Securities and Exchange Commission (the “SEC”) and New York Stock Exchange rules.
Mr. Anquillare meets NYSE independence standards and qualifies as an audit committee financial expert under SEC and NYSE rules. This designation is important for audit committee service and signals strong financial acumen and governance credentials.
Event · Exhibit 99.1
Added in current filing · view on EDGAR →
Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare is the former president and chief operating officer of Verisk Analytics, a strategic data analytics and technology partner to the global insurance industry. He will serve on the board’s Audit & Compensation committees.
Teladoc Health added Mark Anquillare to its board of directors, where he will serve on the Audit and Compensation committees. Anquillare previously served as president and COO of Verisk Analytics, a data analytics and technology company serving the insurance industry. He has over 30 years of financial and executive leadership experience, including serving as Verisk's CFO from 2007 and leading the company through its 2009 IPO.
Show 2 minor / wording changes
Added in current filing · view on EDGAR →
Mr. Anquillare has more than 30 years of financial and executive leadership experience. He served as Verisk’s chief financial officer beginning in 2007, leading the company through its 2009 initial public offering, and later served as Verisk’s chief operating officer, overseeing the company’s insurance and government-facing business as well as several corporate functions.
The filing highlights Anquillare's extensive financial and operational background, including his role leading Verisk through its IPO and his oversight of major business segments and corporate functions. This experience is positioned as relevant to Teladoc's growth and transformation objectives.
Added in current filing · view on EDGAR →
He currently serves on the board of Guidewire Software where he chairs the audit committee and is a member of the business opportunities committee. He also serves on the boards of RegEd and Bamboo Insurance, and he previously served on the board of TruBridge.
Anquillare currently serves on multiple boards, including Guidewire Software where he chairs the audit committee. His concurrent board service demonstrates active governance experience in technology and insurance sectors.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 4, 2026 · How we verify